1910 (formerly 1910 Genetics) is an AI-native biotech company integrating AI, computation, and biological automation to accelerate the design of small molecule and protein therapeutics. Their multimodal AI platform, ITO™, helps biopharma companies transform drug discovery by making undruggable targets a thing of the past.
- Category
- AI Drug Discovery
- Stage
- Series A
- Employees
- 42
- HQ
- Boston, United States
- Founded
- 2018
- Funding
- $30M